On Monday, UroGen Pharma Priced The Public Offering Of 5M Shares At $17.50/Share, Pre-funded Warrants To Purchase 1.14M Shares At $17.499/Pre-funded Warrant, With Gross Proceeds Of Approximately $107.5M
On Monday, UroGen Pharma Priced The Public Offering Of 5M Shares At $17.50/Share, Pre-funded Warrants To Purchase 1.14M Shares At $17.499/Pre-funded Warrant, With Gross Proceeds Of Approximately $107.5M
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.